Audit Committee

G&E Herbal Biotechnology Co.,Ltd. established the “Audit Committee” on June 26, Year 98. Its primary responsibilities include supervising the Company’s financial affairs, the independence and performance of certified public accountants, internal control systems, and the management of other risks.

• Establishment or amendment of internal control systems in accordance with Article 14-1 of the Securities and Exchange Act
• Evaluation of the effectiveness of internal control systems
• Establishment or amendment of procedures for material financial and business activities in accordance with Article 36-1 of the Securities and Exchange Act
• Matters involving conflicts of interest of directors
• Material asset or derivative transactions
• Material loans of funds, endorsements, or guarantees
• Public offering, issuance, or private placement of equity-type securities
• Appointment, dismissal, or remuneration of certified public accountants
• Appointment or dismissal of financial, accounting, or internal audit officers
• Signing or sealing of annual financial reports (Chairman, Manager, and Chief Accounting Officer)
• Supervision of the scope, organizational structure, and operation of risk management
• Other material matters as required by the Company or competent authorities